Paragon Vision Sciences, founded in 1976, is an established player in the Health Care and Manufacturing industries. The company is renowned for its innovative solutions in the realm of contact lenses, particularly its flagship product, the Paragon CRT therapeutic lenses.
Their distinctive approach focuses on Corneal Refractive Therapy, a nightly process that uses specially designed contact lenses to gently reshape the cornea, providing users with crystal-clear vision throughout the day without the need for glasses or surgery. This offering aligns with their slogan: "Experience crystal-clear vision all day, hassle-free and surgery-free, with advanced therapeutic contact lenses designed for nightly use."
The company received a Private Equity Round investment from Summit Partners on 17 October 1995. This long-established investment illustrates the company's capability to sustain and grow over decades. While the headquarters location is unspecified, Paragon Vision Sciences continues to demonstrate its potential as a valuable entity in the therapeutic lens market.
